» Articles » PMID: 26288158

Rational Design of Orthogonal Multipolar Interactions with Fluorine in Protein-Ligand Complexes

Overview
Journal J Med Chem
Specialty Chemistry
Date 2015 Aug 20
PMID 26288158
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Multipolar interactions involving fluorine and the protein backbone have been frequently observed in protein-ligand complexes. Such fluorine-backbone interactions may substantially contribute to the high affinity of small molecule inhibitors. Here we found that introduction of trifluoromethyl groups into two different sites in the thienopyrimidine class of menin-MLL inhibitors considerably improved their inhibitory activity. In both cases, trifluoromethyl groups are engaged in short interactions with the backbone of menin. In order to understand the effect of fluorine, we synthesized a series of analogues by systematically changing the number of fluorine atoms, and we determined high-resolution crystal structures of the complexes with menin. We found that introduction of fluorine at favorable geometry for interactions with backbone carbonyls may improve the activity of menin-MLL inhibitors as much as 5- to 10-fold. In order to facilitate the design of multipolar fluorine-backbone interactions in protein-ligand complexes, we developed a computational algorithm named FMAP, which calculates fluorophilic sites in proximity to the protein backbone. We demonstrated that FMAP could be used to rationalize improvement in the activity of known protein inhibitors upon introduction of fluorine. Furthermore, FMAP may also represent a valuable tool for designing new fluorine substitutions and support ligand optimization in drug discovery projects. Analysis of the menin-MLL inhibitor complexes revealed that the backbone in secondary structures is particularly accessible to the interactions with fluorine. Considering that secondary structure elements are frequently exposed at protein interfaces, we postulate that multipolar fluorine-backbone interactions may represent a particularly attractive approach to improve inhibitors of protein-protein interactions.

Citing Articles

Highlights on U.S. FDA-approved halogen-containing drugs in 2024.

Ali S, Tian X, Meccia S, Zhou J Eur J Med Chem. 2025; 287:117380.

PMID: 39947048 PMC: 11846695. DOI: 10.1016/j.ejmech.2025.117380.


Sulfone Electrophiles in Cross-Electrophile Coupling: Nickel-Catalyzed Difluoromethylation of Aryl Bromides.

Chi B, Gavin S, Ahern B, Peperni N, Monfette S, Weix D ACS Catal. 2024; 14(14):11087-11100.

PMID: 39391026 PMC: 11463998. DOI: 10.1021/acscatal.4c01999.


Parallel Minisci Reaction of -Difluorocycloalkyl Building Blocks.

Holovach S, Poroshyn I, Melnykov K, Liashuk O, Pariiska O, Kolotilov S ACS Org Inorg Au. 2024; 4(4):424-431.

PMID: 39132014 PMC: 11311045. DOI: 10.1021/acsorginorgau.4c00028.


Small Molecule Menin Inhibitors: Novel Therapeutic Agents Targeting Acute Myeloid Leukemia with KMT2A Rearrangement or NPM1 Mutation.

Thomas X Oncol Ther. 2024; 12(1):57-72.

PMID: 38300432 PMC: 10881917. DOI: 10.1007/s40487-024-00262-x.


Stereochemical Analysis of Trifluoroacetamide Derivatives Based on Through- HF Spin-Spin Couplings.

Li Y, Ohtake C, Hotta M, Tabata H, Hirano K, Iida M J Org Chem. 2023; 88(11):7026-7037.

PMID: 37200001 PMC: 10242751. DOI: 10.1021/acs.joc.3c00311.


References
1.
Olsen J, Banner D, Seiler P, Obst Sander U, DArcy A, Stihle M . A fluorine scan of thrombin inhibitors to map the fluorophilicity/fluorophobicity of an enzyme active site: evidence for C-F...C=O interactions. Angew Chem Int Ed Engl. 2003; 42(22):2507-11. DOI: 10.1002/anie.200351268. View

2.
Parlow J, Kurumbail R, Stegeman R, Stevens A, Stallings W, South M . Design, synthesis, and crystal structure of selective 2-pyridone tissue factor VIIa inhibitors. J Med Chem. 2003; 46(22):4696-701. DOI: 10.1021/jm0301686. View

3.
Hamelryck T, Manderick B . PDB file parser and structure class implemented in Python. Bioinformatics. 2003; 19(17):2308-10. DOI: 10.1093/bioinformatics/btg299. View

4.
Biffinger J, Kim H, DiMagno S . The polar hydrophobicity of fluorinated compounds. Chembiochem. 2004; 5(5):622-7. DOI: 10.1002/cbic.200300910. View

5.
Bohm H, Banner D, Bendels S, Kansy M, Kuhn B, Muller K . Fluorine in medicinal chemistry. Chembiochem. 2004; 5(5):637-43. DOI: 10.1002/cbic.200301023. View